Update shared on 11 Dec 2025
Analysts have modestly adjusted their price target on Integrated Diagnostics Holdings. This reflects a recalibration of valuation multiples and long term growth expectations, while core assumptions on fair value, discount rate, revenue growth, and profit margins remain effectively unchanged.
Valuation Changes
- Fair Value per share has remained unchanged at EGP 0.80, indicating that the reassessment did not alter the overall intrinsic value estimate.
- Discount Rate is unchanged at 7.07 percent, suggesting a consistent view of the company’s risk profile and cost of capital.
- Revenue Growth expectations are effectively unchanged at about 19 percent per year, reflecting confidence in the company’s top line expansion trajectory.
- Net Profit Margin assumptions are stable at roughly 20.06 percent, implying no material shift in projected operating efficiency or profitability.
- Future P/E has fallen slightly from 11.93 times to 11.90 times, indicating a modestly lower valuation multiple being applied to the company’s expected earnings.
Have other thoughts on Integrated Diagnostics Holdings?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.